The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vyvanse     Quarter: 2016Q3

Total Drug/Injury Combinations: 363     Number of Pages: 19

DRUGNAME PT EventCount
VYVANSE Psychotic disorder 3 view events
VYVANSE Renal failure 3 view events
VYVANSE Rhabdomyolysis 3 view events
VYVANSE Rosacea 3 view events
VYVANSE Serum serotonin increased 3 view events
VYVANSE Sinusitis 3 view events
VYVANSE Sneezing 3 view events
VYVANSE Therapeutic response increased 3 view events
VYVANSE Tongue coated 3 view events
VYVANSE Treatment noncompliance 3 view events
VYVANSE Abdominal distension 2 view events
VYVANSE Abdominal pain 2 view events
VYVANSE Abnormal loss of weight 2 view events
VYVANSE Acne 2 view events
VYVANSE Affect lability 2 view events
VYVANSE Angina pectoris 2 view events
VYVANSE Aphasia 2 view events
VYVANSE Appetite disorder 2 view events
VYVANSE Atrial fibrillation 2 view events
VYVANSE Autoimmune hepatitis 2 view events

Total Drug/Injury Combinations: 363     Number of Pages: 19

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)